ELUTIA INC (ELUT) Fundamental Analysis & Valuation

NASDAQ:ELUT • US05479K1060

Current stock price

1.07 USD
-0.05 (-4.46%)
At close:
1.0296 USD
-0.04 (-3.78%)
After Hours:

This ELUT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ELUT Profitability Analysis

1.1 Basic Checks

  • ELUT had positive earnings in the past year.
  • ELUT had a negative operating cash flow in the past year.
  • ELUT had negative earnings in each of the past 5 years.
  • In the past 5 years ELUT always reported negative operating cash flow.
ELUT Yearly Net Income VS EBIT VS OCF VS FCFELUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • ELUT's Return On Assets of -90.02% is on the low side compared to the rest of the industry. ELUT is outperformed by 72.25% of its industry peers.
Industry RankSector Rank
ROA -90.02%
ROE N/A
ROIC N/A
ROA(3y)-94.61%
ROA(5y)-70.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ELUT Yearly ROA, ROE, ROICELUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 1K -1K -2K -3K -4K

1.3 Margins

  • ELUT has a Gross Margin of 45.97%. This is in the better half of the industry: ELUT outperforms 73.99% of its industry peers.
  • In the last couple of years the Gross Margin of ELUT has remained more or less at the same level.
  • ELUT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.05%
GM growth 5Y-0.95%
ELUT Yearly Profit, Operating, Gross MarginsELUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ELUT Health Analysis

2.1 Basic Checks

  • ELUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for ELUT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ELUT Yearly Shares OutstandingELUT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ELUT Yearly Total Debt VS Total AssetsELUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -13.99, we must say that ELUT is in the distress zone and has some risk of bankruptcy.
  • ELUT has a Altman-Z score of -13.99. This is amonst the worse of the industry: ELUT underperforms 80.15% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.99
ROIC/WACCN/A
WACC13.45%
ELUT Yearly LT Debt VS Equity VS FCFELUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

  • ELUT has a Current Ratio of 0.44. This is a bad value and indicates that ELUT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.44, ELUT is doing worse than 90.56% of the companies in the same industry.
  • A Quick Ratio of 0.40 indicates that ELUT may have some problems paying its short term obligations.
  • ELUT has a worse Quick ratio (0.40) than 90.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.4
ELUT Yearly Current Assets VS Current LiabilitesELUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ELUT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 142.91% over the past year.
EPS 1Y (TTM)142.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%669.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-40.18%

3.2 Future

  • ELUT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -53.81% yearly.
  • Based on estimates for the next years, ELUT will show a very negative growth in Revenue. The Revenue will decrease by -16.11% on average per year.
EPS Next Y-148.59%
EPS Next 2Y-53.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-36.51%
Revenue Next 2Y-16.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ELUT Yearly Revenue VS EstimatesELUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ELUT Yearly EPS VS EstimatesELUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

2

4. ELUT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 1.01, the valuation of ELUT can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of ELUT indicates a rather cheap valuation: ELUT is cheaper than 99.81% of the companies listed in the same industry.
  • ELUT is valuated cheaply when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • ELUT is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 1.01
Fwd PE N/A
ELUT Price Earnings VS Forward Price EarningsELUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ELUT Per share dataELUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

  • A cheap valuation may be justified as ELUT's earnings are expected to decrease with -53.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-53.81%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ELUT Dividend Analysis

5.1 Amount

  • No dividends for ELUT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ELUT Fundamentals: All Metrics, Ratios and Statistics

ELUTIA INC

NASDAQ:ELUT (3/26/2026, 8:17:25 PM)

After market: 1.0296 -0.04 (-3.78%)

1.07

-0.05 (-4.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-11
Earnings (Next)05-06
Inst Owners35.11%
Inst Owner ChangeN/A
Ins Owners3.22%
Ins Owner Change11.48%
Market Cap45.77M
Revenue(TTM)N/A
Net Income(TTM)-26.47M
Analysts82.5
Price Target3.57 (233.64%)
Short Float %0.46%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.22%
Min EPS beat(2)-32.64%
Max EPS beat(2)43.07%
EPS beat(4)2
Avg EPS beat(4)15.16%
Min EPS beat(4)-32.64%
Max EPS beat(4)52.18%
EPS beat(8)3
Avg EPS beat(8)-32.92%
EPS beat(12)5
Avg EPS beat(12)-27.63%
EPS beat(16)6
Avg EPS beat(16)-23.29%
Revenue beat(2)0
Avg Revenue beat(2)-28.63%
Min Revenue beat(2)-51.01%
Max Revenue beat(2)-6.26%
Revenue beat(4)0
Avg Revenue beat(4)-19.38%
Min Revenue beat(4)-51.01%
Max Revenue beat(4)-6.26%
Revenue beat(8)1
Avg Revenue beat(8)-12.66%
Revenue beat(12)2
Avg Revenue beat(12)-9.2%
Revenue beat(16)4
Avg Revenue beat(16)-6.52%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-21.74%
EPS NQ rev (3m)-16.67%
EPS NY rev (1m)0%
EPS NY rev (3m)16.98%
Revenue NQ rev (1m)-2.94%
Revenue NQ rev (3m)6.45%
Revenue NY rev (1m)-0.53%
Revenue NY rev (3m)-5.26%
Valuation
Industry RankSector Rank
PE 1.01
Fwd PE N/A
P/S 2.17
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.06
EY99.07%
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0.49
BVpS-1.03
TBVpS-1.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -90.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.97%
FCFM N/A
ROA(3y)-94.61%
ROA(5y)-70.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.05%
GM growth 5Y-0.95%
F-Score3
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.32%
Cap/Sales 5.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.4
Altman-Z -13.99
F-Score3
WACC13.45%
ROIC/WACCN/A
Cap/Depr(3y)14.22%
Cap/Depr(5y)13.83%
Cap/Sales(3y)1.73%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)142.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%669.23%
EPS Next Y-148.59%
EPS Next 2Y-53.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-40.18%
Revenue Next Year-36.51%
Revenue Next 2Y-16.11%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.24%
OCF growth 3YN/A
OCF growth 5YN/A

ELUTIA INC / ELUT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ELUTIA INC?

ChartMill assigns a fundamental rating of 1 / 10 to ELUT.


Can you provide the valuation status for ELUTIA INC?

ChartMill assigns a valuation rating of 2 / 10 to ELUTIA INC (ELUT). This can be considered as Overvalued.


Can you provide the profitability details for ELUTIA INC?

ELUTIA INC (ELUT) has a profitability rating of 1 / 10.


How financially healthy is ELUTIA INC?

The financial health rating of ELUTIA INC (ELUT) is 0 / 10.